Telmisartan
Who holds supplier records for Telmisartan? 40 organisations hold a current record for Telmisartan: an active US FDA Type II Drug Master File or a CEP. A further 14 organisations have only historical (inactive) DMF filings. 30 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (27), China (6), Spain (3), Slovenia (2) and 1 other country (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Telmisartan: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/telmisartan
Reading the evidence
- 40 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
27 of the 39 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 17 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (40)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Telmisartan. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Alembic Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 20285 · latest filing Feb 2007
- ALIVUS LIFE SCIENCES LTDIndiaCEP Company GMP cert on recordActive DMF 27804 · latest filing May 2014
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 25810 · latest filing Mar 2012
- CHROMO LABORATORIES INDIA PRIVATE LTDIndiaCEPActive DMF 33989 · latest filing Jul 2019
- Dr. Reddy's Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 19759, 23472 · latest filing Jan 2010
- GLOCHEM INDUSTRIES LTDIndiaCEPActive DMF 38772 · latest filing Oct 2023
- Ipca Laboratories LimitedIndiaCEP Company GMP cert on recordActive DMF 27946 · latest filing Mar 2014
- Macleods Pharmaceuticals Ltd.IndiaCEP Company GMP cert on recordActive DMF 24564 · latest filing Jan 2011
- Mankind Pharma LimitedIndiaCEP Company GMP cert on recordActive DMF 36807 · latest filing Mar 2022
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 20109 · latest filing Jan 2007
- MICRO LABS LTDIndiaCEP Company GMP cert on recordActive DMF 27538 · latest filing Sept 2013
- MSN PHARMACHEM PRIVATE LTDIndiaCEPActive DMF 22731 · latest filing Apr 2009
- TAPI NL BVNetherlandsCEPActive DMF 22123 · latest filing Nov 2008
- Torrent PharmaceuticalsIndiaCEP Company GMP cert on recordActive DMF 24720, 24362 · latest filing Mar 2011
- VASUDHA PHARMA CHEM LTDIndiaCEPActive DMF 38840 · latest filing Sept 2023
- Zhejiang Huahai Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 21466 · latest filing Jul 2007
- Zydus Lifesciences LimitedIndiaCEP Company GMP cert on recordActive DMF 22689 · latest filing Mar 2009
- Cipla LimitedIndia Company GMP cert on recordActive DMF 19987 · latest filing Nov 2006
- Ctx LifesciencesIndiaActive DMF 39926 · latest filing May 2024
- HOLIDAY LABS MEXICO SA DE CVActive DMF 31706 · latest filing May 2017
- JUBILANT BIOSYS LTDIndiaActive DMF 24052 · latest filing Nov 2010
- KP MANISH GLOBAL INGREDIENTS PVT LTDIndiaActive DMF 39821 · latest filing Jun 2024
- SHARON BIO MEDICINE LTDIndia Company GMP cert on recordActive DMF 26123 · latest filing May 2012
- TOPHARMAN SHANDONG CO LTDChinaActive DMF 28309 · latest filing May 2014
- Unichem Laboratories Ltd.India Company GMP cert on recordActive DMF 32621 · latest filing Mar 2018
- Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd.ChinaActive DMF 23829 · latest filing May 2010
- Zhejiang Jingsheng Pharmaceutical Co., Ltd.ChinaActive DMF 41756 · latest filing Jun 2025
- SpainCEP Company GMP cert on record
- Hetero Labs LimitedIndiaCEP Company GMP cert on recordInactive DMF 25029 · latest filing Jun 2011
- IndiaCEP
- SpainCEP
- Sun Pharmaceutical Industries LimitedIndiaCEP Company GMP cert on recordInactive DMF 22352 · latest filing Dec 2008
- ChinaCEP
- ChinaCEP
- K. P. MANISH GLOBAL INGREDIENTS PRIVATE LIMITEDIndiaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- KRKA TOVARNA ZDRAVIL D.D.SloveniaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- VERDANT LIFE SCIENCES PRIVATE LIMITEDIndiaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- RAGHAVA LIFE SCIENCES PRIVATE LIMITEDIndiaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- KRKA, d.d.SloveniaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- Interquim, S.A.SpainCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (30)
Certificates of Suitability on the EDQM register for Telmisartan, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 54 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| HETERO LABS LIMITED Hyderabad | IN | CEP 2022-041 - Rev 01 Telmisartan | Nov 2026 | — |
| K. P. MANISH GLOBAL INGREDIENTS PRIVATE LIMITED Cuddalore | IN | CEP 2024-301 - Rev 01 Telmisartan | Oct 2026 | — |
| KRKA TOVARNA ZDRAVIL D.D. NOVO MESTO Novo mesto | SI | CEP 2021-280 - Rev 01 Telmisartan, 315780 | Aug 2026 | Inspected Jul 2025 Slovenia |
| MANKIND PHARMA LIMITED New Delhi | IN | CEP 2025-135 - Rev 00 Telmisartan, Non-micronised and micronised | Aug 2026 | — |
| MSN PHARMACHEM PRIVATE LIMITED Sangareddy | IN | CEP 2009-108 - Rev 05 Telmisartan, Micronised and non-micronised | Jul 2026 | — |
| CHROMO LABORATORIES INDIA PRIVATE LIMITED Pashamylaram | IN | CEP 2018-104 - Rev 02 Telmisartan | Jul 2026 | — |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Taizhou | CN | CEP 2021-194 - Rev 03 Telmisartan, Process II | Jul 2026 | Inspected May 2026 Italy |
| VASUDHA PHARMA CHEM LIMITED Hyderabad | IN | CEP 2024-216 - Rev 00 Telmisartan | Jun 2026 | — |
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy | IN | CEP 2008-256 - Rev 06 Telmisartan | Jun 2026 | — |
| ALIVUS LIFE SCIENCES LIMITED Mumbai | IN | CEP 2022-047 - Rev 03 Telmisartan, Process II | May 2026 | — |
| MICRO LABS LIMITED Bengaluru | IN | CEP 2020-388 - Rev 03 Telmisartan, Process-II | Mar 2026 | — |
| VERDANT LIFE SCIENCES PRIVATE LIMITED Anakapalli | IN | CEP 2022-366 - Rev 01 Telmisartan | Feb 2026 | Inspected Oct 2024 Germany |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2020-290 - Rev 03 Telmisartan, Site II | Sept 2025 | — |
| RAGHAVA LIFE SCIENCES PRIVATE LIMITED Hyderabad | IN | CEP 2024-253 - Rev 00 Telmisartan | Aug 2025 | — |
| ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD. Taizhou City | CN | CEP 2025-215 - Rev 00 Telmisartan, Process II | Aug 2025 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 2010-301 - Rev 05 Telmisartan | Jul 2025 | — |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai | IN | CEP 2009-229 - Rev 02 Telmisartan | Jul 2025 | — |
| IPCA LABORATORIES LIMITED Mumbai | IN | CEP 2024-457 - Rev 01 Telmisartan, WT6 process | Jun 2025 | — |
| GLOCHEM INDUSTRIES PRIVATE LIMITED Hyderabad | IN | CEP 2023-340 - Rev 00 Telmisartan | Dec 2024 | — |
| ZHUHAI RUNDU PHARMACEUTICAL CO., LTD. Sanzao Town | CN | R0-CEP 2022-179 - Rev 00 Telmisartan | Aug 2023 | — |
| KRKA, d.d., Novo mesto Novo mesto | SI | R1-CEP 2015-307 - Rev 01 Telmisartan | May 2023 | — |
| Moehs Iberica S.L. Rubi | ES | R1-CEP 2012-266 - Rev 02 Telmisartan | Jan 2023 | — |
| DR. REDDY'S LABORATORIES LIMITED Hyderabad | IN | R1-CEP 2010-165 - Rev 03 Telmisartan | Nov 2022 | — |
| JUBILANT PHARMOVA LIMITED Nanjangud | IN | R1-CEP 2011-209 - Rev 01 Telmisartan | Aug 2022 | — |
| ZYDUS LIFESCIENCES LIMITED Vadodara | IN | R1-CEP 2009-235 - Rev 02 Telmisartan | Jul 2022 | — |
| ALEMBIC PHARMACEUTICALS LIMITED Vadodara | IN | R1-CEP 2008-217 - Rev 07 Telmisartan | May 2022 | — |
| TORRENT PHARMACEUTICALS LIMITED Village Bhat | IN | R1-CEP 2011-256 - Rev 02 Telmisartan | Sept 2020 | — |
| AGC PHARMA CHEMICALS EUROPE S.L.U. Malgrat De Mar | ES | R1-CEP 2009-054 - Rev 03 Telmisartan | Dec 2019 | — |
| Interquim, S.A. Sant Cugat Del Vallès | ES | R1-CEP 2010-363 - Rev 00 Telmisartan | Feb 2019 | — |
| MACLEODS PHARMACEUTICALS LIMITED Mumbai | IN | R1-CEP 2011-072 - Rev 00 Telmisartan | May 2018 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (14)
Organisations whose Type II DMFs for Telmisartan are no longer active. These show a past filing, not current supply.
Show all 14 historical records
- India · Inactive DMF 31823 · filed Aug 2017
- India · Inactive DMF 26536 · filed Oct 2012
- India · Inactive DMF 26028 · filed May 2012
- SIGNA SA DE CVInactive DMF 25742 · filed Jan 2012
- Italy · Inactive DMF 24703 · filed May 2011
- India · Inactive DMF 24638 · filed Mar 2011
- India · Inactive DMF 24472 · filed Jan 2011
- Jiangxi Synergy Pharmaceutical Co., LtdChina · Inactive DMF 24211 · filed Sept 2010
- SEQUEL PHARMACHEM PRIVATE LTDInactive DMF 22768 · filed May 2009
- India · Inactive DMF 22443 · filed Jan 2009
- Amino Chemicals LtdMalta · Inactive DMF 20882 · filed Sept 2007
- Teva Pharmaceutical Industries Ltd.Israel · Inactive DMF 20571 · filed Jun 2007
- India · Inactive DMF 20575 · filed May 2007
- India · Inactive DMF 18759 · filed Sept 2005
Overview
Telmisartan is an angiotensin II receptor antagonist used in the treatment of hypertension. It may also reduce the risk of cardiovascular events in patients with high cardiovascular risk.
Chemical identity
- IUPAC name
- 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid
- Canonical SMILES
- CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
- InChIKey
- RMMXLENWKUUMAY-UHFFFAOYSA-N
- Synonyms
- Micardis API, bibr 277 se, bibr-277, bibr-277 se, bibr-277-se, c09ca07, kinzalkomb component telmisartan, kinzalmono, micardis, micardis hct component telmisartan, micardisplus component telmisartan, onduarp component telmisartan
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Angiotensin 2 Receptor Blocker
- Mechanism of action
- Angiotensin 2 Receptor Antagonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Telmisartan?
40 organisations hold an active US FDA Type II Drug Master File or a CEP for Telmisartan: Alembic Pharmaceuticals Limited (India), ALIVUS LIFE SCIENCES LTD (India), APITORIA PHARMA PRIVATE LTD (India), CHROMO LABORATORIES INDIA PRIVATE LTD (India), Dr. Reddy's Laboratories Ltd. (India), GLOCHEM INDUSTRIES LTD (India), Ipca Laboratories Limited (India) and Macleods Pharmaceuticals Ltd. (India), and 32 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Telmisartan Drug Master Files are active?
Alembic Pharmaceuticals Limited (DMF 20285), ALIVUS LIFE SCIENCES LTD (DMF 27804), APITORIA PHARMA PRIVATE LTD (DMF 25810), CHROMO LABORATORIES INDIA PRIVATE LTD (DMF 33989), Dr. Reddy's Laboratories Ltd. (DMF 19759, 23472), GLOCHEM INDUSTRIES LTD (DMF 38772), Ipca Laboratories Limited (DMF 27946) and Macleods Pharmaceuticals Ltd. (DMF 24564) and 19 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Telmisartan records mean?
14 organisations have only inactive Type II DMFs for Telmisartan. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Telmisartan have a European Certificate of Suitability?
Yes. 30 organisations hold a valid CEP for Telmisartan on the EDQM register, including HETERO LABS LIMITED Hyderabad (IN), K. P. MANISH GLOBAL INGREDIENTS PRIVATE LIMITED Cuddalore (IN), KRKA TOVARNA ZDRAVIL D.D. NOVO MESTO Novo mesto (SI), MANKIND PHARMA LIMITED New Delhi (IN), MSN PHARMACHEM PRIVATE LIMITED Sangareddy (IN) and CHROMO LABORATORIES INDIA PRIVATE LIMITED Pashamylaram (IN) and 24 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Telmisartan supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Telmisartan?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.